Aslan Fred 4
4 · Artiva Biotherapeutics, Inc. · Filed Oct 17, 2025
Insider Transaction Report
Form 4
Aslan Fred
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2025-10-17$6.00/sh−25,500$153,000→ 356,721 total
Footnotes (1)
- [F1]Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on July 23, 2024.